<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>DIGIFab - Clinical Monitoring Opportunity</title>
<style>
/* Existing styles remain unchanged */
/* New style for the indications text box */
.indications {
grid-row: 1;
overflow-y: auto; /* Enable vertical scrolling */
padding: 0 10px; /* Add padding to the right side */
}
.indications-text {
font-size: 11px;
white-space: pre-wrap; /* Preserve line breaks in the text */
}
</style>
</head>
<body>
<div class="container">
<img class="logo" src="https://serb.com/wp-content/uploads/2022/09/SERB-logo-200x57-1.svg" alt="SERB Logo">
<div class="content">
<p class="heading">Clinical Monitoring Opportunity!</p>
<p class="subheading">Monitor Digoxin Levels for Patient Safety</p>
<p class="text">This patient is on digoxin. Monitoring levels (~6 hours post-dose) is crucial for early detection of life-threatening toxicities. Act now and verify digoxin levels are within therapeutic range to optimize patient care. Click to Learn More:</p>
<a href="https://digifab.health/en-us/digoxin-toxicity/potentially-fatal-digoxin-toxicity.html" class="button">Potentially Fatal Digoxin Toxicity | DIGIFab</a>
</div>
<div class="indications">
<p class="indications-text">
INDICATIONS AND USAGE
DIGIFab is indicated for the treatment of patients with life-threatening or potentially life-threatening digoxin toxicity or overdose, including:
Known suicidal or accidental consumption of fatal doses of digoxin: 10 mg or more of digoxin in healthy adults, or 4 mg (or more than 0.1 mg/kg) in healthy children, or ingestion of an amount that can cause steady state serum concentrations of ≥10 ng/mL;
Chronic ingestions causing steady-state serum digoxin concentrations >6 ng/mL in adults or 4 ng/mL in children;
Manifestations of life-threatening toxicity of digoxin overdose such as severe ventricular arrhythmias, progressive bradycardia, and second or third degree heart block not responsive to atropine, serum potassium levels exceeding 5.5 mEq/L in adults or 6 mEq/L in children with rapidly progressive signs and symptoms of digoxin toxicity.
IMPORTANT SAFETY INFORMATION
Warnings and Precautions
General
Suicidal ingestion may result from more than one drug. Consider toxic effects of other drugs or poisons in cases where signs and symptoms of digitalis toxicity are not relieved by administration of DIGIFab.
Rapid drop in serum potassium concentration
</p>
</div>
</div>
</body>
</html>
2
2
4KB
11KB
104.0ms
185.0ms
191.0ms